EVALUATION OF THE EFFECT OF METFORMIN ON SERUM INFLAMMATORY BIOMARKERS (CRP, IL-6) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. The Research of Medical Science Review, [S. l.], v. 3, n. 5, p. 982–987, 2025. Disponível em: https://www.thermsr.com/index.php/Journal/article/view/1235.. Acesso em: 17 jul. 2025.